Correction: Chen et al. Bicalutamide Exhibits Potential to Damage Kidney via Destroying Complex I and Affecting Mitochondrial Dynamics. J. Clin. Med. 2022, 11, 135
Kuan-Chou Chen, Chang-Rong Chen, Chang-Yu Chen, Chiung-Chi Peng, Robert Y. Peng
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMitochondrial Function and Pathology · Biochemical Acid Research Studies · Chemotherapy-induced organ toxicity mitigation
In the original publication [1], reference [29] is an online, third party advertisement. It has been deleted. The quoting sentence in the Introduction Section “A report from the U.S. Food and Drug Administration demonstrated that up to 37.5% of patients who have taken Bic therapy for 1–6 months may experience kidney failure [29]” has been removed. With this correction, the order of some references has been adjusted accordingly.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
The reference list from the paper itself. Each links out to its DOI / PubMed record.